Medical Cannabis

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD-related medical research.

A scoping review of 41 studies finds physicians nationwide report a lack sufficient training to counsel patients on medical cannabis use, with mixed perceptions on favorability of its use.

Here, we bring you our top five recent articles covering veterans and medical cannabis, cannabis legalized by the Omaha tribe, low THC extracts for Rett syndrome, ICE raids at a cannabis farm, and our newest Noid Factoid.

The “Big, Beautiful Bill” signed recently into law by President Donald Trump, includes an amendment that may end the medical cannabis ban in the VA which has prevented doctors from recommending the plant to their patients.

Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.

Webinar Date/Time: Tue, Aug 5, 2025 2:00 PM EDT

Webinar Date/Time: Wed, Jul 30, 2025 11:00 AM EDT

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

The newly published regulations classify cannabis flowers as controlled herbs, requiring prescriptions and licensed handling.

Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.

A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.

Hawaii Governor Josh Green vetoes bill that would have allowed medical cannabis patients to be certified via telehealth.

According to two House Bills, medical cannabis must now be sold in pre-packaged form, with new regulations and licenses for transportation, storage, and security of facilities.

In this month’s webinar, Dustin Sulak, DO, summarizes and provides insights on cannabis studies for chronic pain, restless leg syndrome, insomnia, effects on driving, and more.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

Researchers analyzed data from 262 counties, identifying sociodemographic characterizations, associations, and discrepancies.

Curaleaf International and Jupiter Research LLC, announce the first liquid inhalation device has received an EU medical device certification.

Recently introduced legislation in Maine focuses on testing and safety for medical cannabis in the state.

Here, we bring you our top five recent articles covering a cannabis advertising ban in Mississippi, reforms urged in Canada, the latest Healer webinar, a study on THC and driving skills, and intoxicating hemp product sales in Ohio.

The large-scale analysis focused on the language of the studies to establish positive, negative, or neutral associations with cannabis and cancer.

The latest webinar covered five studies on cannabis for various conditions including hypermobility, eczema, Parkinson’s disease, and other conditions.

Patients in Australia with chronic health conditions evaluated the effects on their quality of life, changes in pain, and more after 12 months of medical cannabis.

Here, we bring you our top four recent articles covering standards in the cannabis industry, a cannabis for sleep survey, a new research and resource center at the University of Mississippi, and in-person information sessions from Metrc.

The survey included responses from over one thousand medical cannabis patients, plus an analysis of trends in the medical cannabis market.

This month’s Healer webinar explored how recent cannabis policies impact patients, parents, and more.

Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.

Webinar Date/Time: Thu, Mar 20, 2025 10:00 AM EDT

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.

This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.

The Alabama Medical Cannabis Commission made the announcement in its most recent meeting, intending to advance the state medical cannabis program.